Published in Antimicrob Agents Chemother on November 01, 1991
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol (1992) 12.13
Antifungal susceptibility testing. Clin Microbiol Rev (1993) 9.04
Resistance of Candida species to fluconazole. Antimicrob Agents Chemother (1995) 9.04
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev (1999) 5.84
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother (1993) 3.79
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol (1994) 3.51
Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol (1993) 2.87
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother (2002) 2.33
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob Agents Chemother (2000) 2.33
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol (1996) 2.19
Fluconazole disk diffusion susceptibility testing of Candida species. J Clin Microbiol (1998) 1.72
Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia. Antimicrob Agents Chemother (1999) 1.51
Azole resistance in Candida. Eur J Clin Microbiol Infect Dis (1997) 1.23
Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.22
Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model. Antimicrob Agents Chemother (1996) 1.22
Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrob Agents Chemother (2006) 1.22
Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother (1999) 1.20
Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J Clin Microbiol (2003) 1.04
Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole. Antimicrob Agents Chemother (1995) 1.04
Trends in antifungal susceptibility among Candida sp. Urinary isolates from 1994 and 1998. J Clin Microbiol (2000) 1.03
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Antimicrob Agents Chemother (1995) 0.99
Genetic structure of Candida glabrata populations in AIDS and non-AIDS patients. J Clin Microbiol (2002) 0.97
Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole. Antimicrob Agents Chemother (1995) 0.96
In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling. Antimicrob Agents Chemother (2006) 0.94
Efficacy of D0870 treatment of experimental Candida vaginitis. Antimicrob Agents Chemother (1997) 0.92
Which tree orders in southern Africa have the highest antimicrobial activity and selectivity against bacterial and fungal pathogens of animals? BMC Complement Altern Med (2014) 0.92
Structure-activity relationships among antifungal nylon-3 polymers: identification of materials active against drug-resistant strains of Candida albicans. J Am Chem Soc (2014) 0.89
Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors. Antimicrob Agents Chemother (1996) 0.86
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations. Antimicrob Agents Chemother (1997) 0.85
Quality control limits for posaconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J Clin Microbiol (2006) 0.82
Antifungal agents in neonatal systemic candidiasis. Antimicrob Agents Chemother (1995) 0.82
A chemically modified tetracycline (CMT-3) is a new antifungal agent. Antimicrob Agents Chemother (2002) 0.78
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection (2013) 0.78
Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother (1990) 8.42
Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 5.46
Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother (1980) 4.53
Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis (1984) 4.42
Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med (1986) 3.34
In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol (1988) 2.88
Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates. Antimicrob Agents Chemother (1982) 2.17
Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata. J Antimicrob Chemother (1986) 2.03
Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. J Med Vet Mycol (1988) 1.85
Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am J Med (1986) 1.50
9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.32
Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1990) 1.14
Cytomegalovirus esophagogastritis in a patient with acquired immunodeficiency syndrome. Am J Gastroenterol (1985) 0.98
Fluconazole treatment of fungal infections in the immunocompromised host. Semin Oncol (1990) 0.93
Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60
Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage (2001) 12.61
Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med (2003) 12.09
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci (2003) 10.44
fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage (2005) 8.61
Transgenic plant aequorin reports the effects of touch and cold-shock and elicitors on cytoplasmic calcium. Nature (1991) 6.73
Tensorial extensions of independent component analysis for multisubject FMRI analysis. Neuroimage (2005) 5.33
Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex (2007) 5.28
Bicycle-associated head injuries and deaths in the United States from 1984 through 1988. How many are preventable? JAMA (1991) 4.76
Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry (2008) 4.70
The Human Connectome Project: a data acquisition perspective. Neuroimage (2012) 4.64
Changes in connectivity profiles define functionally distinct regions in human medial frontal cortex. Proc Natl Acad Sci U S A (2004) 4.19
134 battered children: a medical and psychological study. Br Med J (1974) 3.85
Resistance gene complexes: evolution and utilization. Annu Rev Phytopathol (2001) 3.80
National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample. Health Serv Res (1999) 3.72
Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum (2009) 3.61
The major chlorophyll a/b binding protein of petunia is composed of several polypeptides encoded by a number of distinct nuclear genes. J Mol Appl Genet (1983) 3.54
Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med (1986) 3.34
Light-stimulated accumulation of transcripts of nuclear and chloroplast genes for ribulosebisphosphate carboxylase. J Mol Appl Genet (1981) 3.28
Wind-induced plant motion immediately increases cytosolic calcium. Proc Natl Acad Sci U S A (1992) 3.18
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med (1994) 3.09
Data on the incidence, segregation and linkage relations of the adenylate kinase (AK) polymorphism. Ann Hum Genet (1968) 2.91
Species identification of coagulase-negative staphylococcal isolates from blood cultures. J Clin Microbiol (1982) 2.71
Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1985) 2.58
Genetic control over the resting brain. Proc Natl Acad Sci U S A (2010) 2.45
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 2.29
A critical role for disproportionating enzyme in starch breakdown is revealed by a knock-out mutation in Arabidopsis. Plant J (2001) 2.26
Postgerminative growth and lipid catabolism in oilseeds lacking the glyoxylate cycle. Proc Natl Acad Sci U S A (2000) 2.26
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother (1991) 2.26
Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit. Proc Natl Acad Sci U S A (1999) 2.23
Changes in white matter microstructure during adolescence. Neuroimage (2007) 2.22
Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J (1997) 2.16
Innate recognition of coral snake pattern by a possible avian predator. Science (1975) 2.07
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage (2011) 2.06
Longitudinal changes in grey and white matter during adolescence. Neuroimage (2009) 2.03
5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat. Gastroenterology (1988) 1.98
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc (2000) 1.97
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology (2003) 1.94
An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase. J Antimicrob Chemother (1991) 1.91
Removal of FMRI environment artifacts from EEG data using optimal basis sets. Neuroimage (2005) 1.91
Requirement for 3-ketoacyl-CoA thiolase-2 in peroxisome development, fatty acid beta-oxidation and breakdown of triacylglycerol in lipid bodies of Arabidopsis seedlings. Plant J (2001) 1.87
Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev (2008) 1.84
Characterisation of three cDNA clones encoding different mRNAs for the precursor to the small subunit of wheat ribulosebisphosphate carboxylase. Nucleic Acids Res (1983) 1.76
Saccharomyces cerevisiae infections in man. Sabouraudia (1984) 1.76
Head injury-associated deaths in the United States from 1979 to 1986. JAMA (1989) 1.75
Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.74
An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem (1997) 1.73
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther (2011) 1.73
Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis (2007) 1.73
Pseudomonas mesophilica infections in humans. J Clin Microbiol (1985) 1.71
Elimination of rabies from red foxes in eastern Ontario. J Wildl Dis (2001) 1.70
Who smokes in Hollywood? Characteristics of smokers in popular films from 1940 to 1989. Addict Behav (1998) 1.68
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1996) 1.68
Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus. J Virol (1998) 1.66
Serum cryptococcal antigen determination in the presence of rheumatoid factor. J Clin Microbiol (1981) 1.66
Serum levels of arabinitol in the detection of invasive candidiasis in animals and humans. J Infect Dis (1981) 1.65
Resistance exercise as a countermeasure to disuse-induced bone loss. J Appl Physiol (1985) (2004) 1.61
Day-to-day variation in iron-status indices in healthy men and women. Am J Clin Nutr (1991) 1.59
Recombination between paralogues at the Rp1 rust resistance locus in maize. Genetics (2001) 1.58
Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage (2010) 1.57
Impaired immunity in vitamin A-deficient mice. J Nutr (1987) 1.56
Seizure propensity with imipenem. Arch Intern Med (1989) 1.54
A prospective randomized study of 4.1 French catheters utilizing the percutaneous right brachial approach for the diagnosis of coronary artery disease. Cathet Cardiovasc Diagn (1992) 1.53
Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection. Arch Intern Med (1985) 1.52
Synthesis of the small subunit of ribulose-bisphosphate carboxylase from genes cloned into plasmids containing the SP6 promoter. Biochem J (1986) 1.52
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. Aliment Pharmacol Ther (2011) 1.51
Temporally-regulated retinoic acid depletion produces specific neural crest, ocular and nervous system defects. Development (1997) 1.50
Parents of battered babies: a controlled study. Br Med J (1973) 1.49
Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis (1989) 1.49
Field efficacy of ivermectin, fenbendazole and pyrantel embonate paste anthelmintics in horses. Vet Rec (1989) 1.47
IgA nephropathy: characterization of the light chains. Clin Nephrol (1990) 1.43
Pathogenicity of Eikenella corrodens in humans. Arch Intern Med (1983) 1.42
Comparative evaluation of identification systems for testing methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol (1986) 1.42
Inoculum effect of beta-lactam antibiotics on Enterobacteriaceae. Antimicrob Agents Chemother (1985) 1.40
Esophageal irritation due to alendronate sodium tablets: possible mechanisms. Dig Dis Sci (1998) 1.39
Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology (2008) 1.39
Aortic aneurysm leak after streptokinase treatment for myocardial infarction. Eur J Vasc Surg (1993) 1.39
Eosinophilia, myalgia associated with L-tryptophan use: case report. Va Med (1990) 1.38
Clindamycin elimination in patients with liver disease. J Antimicrob Chemother (1981) 1.38
Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis. Aliment Pharmacol Ther (2008) 1.36
Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations. Antimicrob Agents Chemother (1989) 1.34
The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1986) 1.33
Failure to thrive and anorexia nervosa. Postgrad Med J (1972) 1.32
Overview: surveillance for selected public health indicators affecting older adults--United States. MMWR CDC Surveill Summ (1999) 1.32
V-Amylose at atomic resolution: X-ray structure of a cycloamylose with 26 glucose residues (cyclomaltohexaicosaose). Proc Natl Acad Sci U S A (1999) 1.31
Evaluation of the AutoMicrobic system for identification of glucose-nonfermenting gram-negative rods. J Clin Microbiol (1982) 1.30
Retrospective analysis of plasmid patterns in a study of burn unit outbreaks of infection due to Enterobacter cloacae. J Infect Dis (1983) 1.29
Mycobacterium xenopi infection in a patient with acquired immunodeficiency syndrome. Chest (1984) 1.27
Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer. Ann Oncol (2005) 1.22